TScan Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
TCRX Nasdaq 2836 www.tscan.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for TScan Therapeutics, Inc.

TScan Therapeutics Announces Positive Updated Data from the ALLOHA™ Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition - Dec 6th, 2025 3:30 pm
TScan Therapeutics to Host Virtual KOL Event to Discuss Clinical Updates from the ALLOHA™ Phase 1 Trial and Future Market Opportunities - Dec 3rd, 2025 2:05 pm
TScan Therapeutics, Inc. (TCRX) Reports Q3 Loss, Lags Revenue Estimates - Nov 12th, 2025 6:25 am
TScan Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - Nov 12th, 2025 5:00 am
Arcturus Therapeutics (ARCT) Reports Q3 Loss, Beats Revenue Estimates - Nov 10th, 2025 3:10 pm
Novavax (NVAX) Reports Q3 Loss, Beats Revenue Estimates - Nov 6th, 2025 7:15 am
Arvinas, Inc. (ARVN) Reports Q3 Loss, Tops Revenue Estimates - Nov 5th, 2025 6:20 am
TScan Therapeutics to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference - Nov 5th, 2025 5:00 am
TScan Therapeutics Reaches Agreement with FDA on Pivotal Study Design for TSC-101 and Announces Strategic Prioritization to Advance TSC-101 and Extend Cash Runway into H2 2027 - Nov 3rd, 2025 4:30 am
Alnylam Pharmaceuticals (ALNY) Q3 Earnings and Revenues Top Estimates - Oct 30th, 2025 7:15 am
2 Overlooked Stocks to Snap Up in 2025 - Oct 16th, 2025 5:30 am
TScan Therapeutics Announces Upcoming Oral and Poster Presentations at the American College of Rheumatology Convergence 2025 - Sep 17th, 2025 5:00 am
TScan Therapeutics to Participate in Upcoming Investor Conferences - Sep 3rd, 2025 5:00 am
TScan Therapeutics (NASDAQ:TCRX) Will Have To Spend Its Cash Wisely - Aug 15th, 2025 7:36 am
TScan Therapeutics, Inc. (TCRX) Reports Q2 Loss, Beats Revenue Estimates - Aug 12th, 2025 1:00 pm
TScan Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - Aug 12th, 2025 5:00 am
Urogen Pharma (URGN) Reports Q2 Loss, Lags Revenue Estimates - Aug 7th, 2025 7:15 am
Mirum Pharmaceuticals, Inc. (MIRM) Reports Q2 Loss, Tops Revenue Estimates - Aug 6th, 2025 3:55 pm
Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates - Aug 4th, 2025 6:25 am
One TScan Therapeutics Insider Raised Stake By 18% In Previous Year - Jul 19th, 2025 6:21 am